Opening New Markets Through Mexican Clinical Trial Registration. Saves 80 + million dollars. Our aim is to complete the remaining clinical trials and to register Narhex DG 35/17 Prodrug initially in Mexico, followed by using the approved DG35/17 Prodrug MoH registration from the Mexican Health depar...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2018 (8 years)
Address:
null
LOW
spending power
